covid 19 News and Research

RSS

Are self-sanitizing disinfectants containing quaternary ammonium compounds truly effective against respiratory viruses?

Researchers evaluated the antimicrobial efficiency of two commercially available disinfectants containing quaternary ammonium compounds against influenza A virus (hemagglutinin 1 neuraminidase 1 (H1N1)), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and human coronavirus 229E.

9 Mar 2023

Individuals with autosomal and X-linked recessive deficiency of IRAK-4 and MyD88 are more susceptible to developing hypoxemic COVID-19 pneumonia

Researchers identified that individuals with a deficiency of myeloid differentiation primary response 88 (MyD88) and interleukin-1 receptor-associated kinase 4 (IRAK-4) due to an autosomal recessive condition were highly susceptible to developing hypoxemic coronavirus disease 2019 (COVID-19) pneumonia when infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

9 Mar 2023

What is the gastrointestinal impact of Long Covid?

Researchers assessed gastrointestinal outcomes associated with COVID-19.

9 Mar 2023

Nasal administration of a fully human anti-CD3 monoclonal antibody modulates T cell inflammatory responses in COVID-19

Researchers assessed the impact of an anti-CD3 monoclonal antibody called Foralumab in COVID-19 treatment.

9 Mar 2023

ACE2: its diverse functions, relationship with SARS-CoV-2, and the implications for COVID-19 disease sequelae

Researchers assessed the role of ACE2 in the COVID-19 pandemic.

9 Mar 2023

Early outpatient treatment of COVID-19 with metformin could reduce the risk of developing long COVID

In a recent study posted to Preprints with The Lancet*, a team of researchers from the United States investigated whether early outpatient treatment of coronavirus disease 2019 (COVID-19) patients with fluvoxamine, ivermectin, or metformin could prevent long coronavirus disease (long COVID).

9 Mar 2023

Evaluating SARS-CoV-2 bivalent booster vaccine against severe COVID-19 outcomes

In a recent study posted to the medRxiv* preprint server, researchers assessed the effectiveness of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) bivalent booster vaccine against severe SARS-CoV-2 infection outcomes.

9 Mar 2023

Evolutionary convergence of the SARS-CoV-2 A-lineage spike sequences

Researchers assessed the impact of evolutionary convergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) A-lineage (Clade 19B) spike sequences on B-lineage viral replication.

9 Mar 2023

Medicaid health plans try to protect members — and profits — during unwinding

The federal covid-19 pandemic protections that have largely prohibited states from dropping anyone from Medicaid since 2020 helped millions of low-income Americans retain health insurance coverage — even if they no longer qualified — and brought the U.S. uninsured rate to a record low.

9 Mar 2023

New 'Know Your Neighbourhood Fund' to support charitable projects in reducing loneliness in deprived areas

Launched by the government working in partnership with The National Lottery Community Fund, Arts Council England, The National Lottery Heritage Fund, Historic England and UK Community Foundations (UKCF), the 'Know Your Neighbourhood Fund' will support local organizations in (27 areas) to increase their offer of projects that enrich lives to help improve wellbeing and social connections.

8 Mar 2023

Researchers explore non-adherence to COVID-19 public health measures by parents

In a recent study published in JAMA Network Open, researchers analyzed parents' non-adherence to public health measures (PHMs) against coronavirus disease 2019 (COVID-19) for their children.

8 Mar 2023

Novel molecular mechanism responsible for common form of acquired hydrocephalus discovered

Mass General researchers have discovered a novel molecular mechanism responsible for the most common forms of acquired hydrocephalus, potentially opening the door to the first-ever nonsurgical treatment for a life-threatening disease that affects about a million Americans.

8 Mar 2023

Pilot trial tests nasal monoclonal antibody treatment for COVID-19

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody.

8 Mar 2023

Exploring the prevalence of COVID-19 symptoms in post-acute COVID-19 phase among children and young people

In a recent study published in PLoS ONE, researchers prospectively followed up with children and young people (CYP) diagnosed with post-coronavirus disease 2019 (COVID-19) condition or long COVID to elucidate long COVID symptom profiles over six months.

8 Mar 2023

Study shows correlations between symptoms of long COVID and physical inactivity

The link between symptoms of COVID-19 and physical inactivity is increasingly evident.

8 Mar 2023

COVID-19 patients at increased risk of developing gastrointestinal disorders

People who have had COVID-19 are at increased risk of developing gastrointestinal (GI) disorders within a year after infection compared with people who haven't been infected, according to an analysis of federal health data by researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system.

8 Mar 2023

Dementia the strongest risk factor for infection with COVID-19 in older people

Study finds community-onset bacterial coinfection in children with critical COVID-19 is infrequent but empiric antibiotics are commonly prescribed

Researchers evaluated the use of empiric antibiotics to determine the prevalence rates of community-acquired bacterial coinfections among hospitalized pediatric critical COVID-19 patients.

8 Mar 2023

covid 19 News and Research

Are self-sanitizing disinfectants containing quaternary ammonium compounds truly effective against respiratory viruses?

Individuals with autosomal and X-linked recessive deficiency of IRAK-4 and MyD88 are more susceptible to developing hypoxemic COVID-19 pneumonia

What is the gastrointestinal impact of Long Covid?

Nasal administration of a fully human anti-CD3 monoclonal antibody modulates T cell inflammatory responses in COVID-19

ACE2: its diverse functions, relationship with SARS-CoV-2, and the implications for COVID-19 disease sequelae

Early outpatient treatment of COVID-19 with metformin could reduce the risk of developing long COVID

Evaluating SARS-CoV-2 bivalent booster vaccine against severe COVID-19 outcomes

Evolutionary convergence of the SARS-CoV-2 A-lineage spike sequences

Medicaid health plans try to protect members — and profits — during unwinding

New 'Know Your Neighbourhood Fund' to support charitable projects in reducing loneliness in deprived areas

Researchers explore non-adherence to COVID-19 public health measures by parents

Novel molecular mechanism responsible for common form of acquired hydrocephalus discovered

Pilot trial tests nasal monoclonal antibody treatment for COVID-19

Exploring the prevalence of COVID-19 symptoms in post-acute COVID-19 phase among children and young people

Study shows correlations between symptoms of long COVID and physical inactivity

COVID-19 patients at increased risk of developing gastrointestinal disorders

Dementia the strongest risk factor for infection with COVID-19 in older people

Increased prevalence of overweight and obesity among Swedish children during the pandemic

The importance of ketones from a clinical and medical perspective

Study finds community-onset bacterial coinfection in children with critical COVID-19 is infrequent but empiric antibiotics are commonly prescribed

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News